Nilaya Varma, Co-founder and Group CEO, Primus Partners, highlighted that the surge in genetic testing in India is being driven by rising demand for cancer diagnostics, pediatric and reproductive health applications like prenatal and carrier testing, as well as growing interest in rare genetic disease testing due to the country's vast genetic diversity.